Deciphering the role of lipoproteins and lipid metabolic alterations in ageing and ageing-associated renal fibrosis
Ageing Research Reviews · 2023-03 · 85 · 101861
DOI: 10.1016/j.arr.2023.101861 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2023-03. Verfasst von Hong-Jiao Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Zhejiang Chinese Medical University, No. 548 Binwen Road, Hangzhou, Zhejiang 310053, China. Hauptthemen laut MEDLINE: Quality of Life, Kidney Diseases. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 156 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Technologies Research and Development Program, National Key Research and Development Program of China.
Abstract (Originalsprache)
Fibrosis is the ultimate pathological feature of many chronic diseases, and ageing a major risk factor for fibrotic diseases. Current therapies are limited to those that reduce the rate of functional decline in patients with mild to moderate disease, but few interventions are available to specifically target the pathogenesis of fibrosis. In this context, new treatments that can significantly improve survival time and quality of life for these patients are urgently needed. In this review, we outline both the synthesis and metabolism of lipids and lipoproteins associated with ageing-associated renal fibrosis and the prominent contribution of lipids and lipidomics in the discovery of biomarkers that can be used for the prevention, diagnosis, and treatment of renal ageing and fibrosis. Next, we describe the effect of dyslipidaemia on ageing-related renal fibrosis and the pathophysiological changes in the kidney caused by dyslipidaemia. We then summarize the enzymes, transporters, transcription factors, and RNAs that contribute to dysregulated lipid metabolism in renal fibrosis and discuss their role in renal fibrosis in detail. We conclude by discussing the progress in research on small molecule therapeutic agents that prevent and treat ageing and ageing-associated renal fibrosis by modulating lipid metabolism. A growing number of studies suggest that restoring aberrant lipid metabolism may be a novel and promising therapeutic strategy to combat ageing and ageing-associated renal fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Zhejiang Chinese Medical University, No. 548 Binwen Road, Hangzhou, Zhejiang 310053, China.
- Guangdong Nephrotic Drug Engineering Technology Research Center, Institute of Consun Co. for Chinese Medicine in Kidney Diseases, Guangdong Consun Pharmaceutical Group, No. 71 Dongpeng Avenue, Guangzhou, Guangdong 51053…
- Department of Urology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 South of Panjiayuan, Beijing 100021, China. Electronic address: liufei_2359@163.com.
- School of Pharmacy, Zhejiang Chinese Medical University, No. 548 Binwen Road, Hangzhou, Zhejiang 310053, China. Electronic address: caogang33@163.com.
- School of Pharmacy, Zhejiang Chinese Medical University, No. 548 Binwen Road, Hangzhou, Zhejiang 310053, China. Electronic address: zhaoyybr@163.com.
Förderung
- National Natural Science Foundation of China
- Key Technologies Research and Development Program
- National Key Research and Development Program of China
Zitieren
APA
Liu, H. J., Miao, H., Yang, J. Z., Liu, F., Cao, G., & Zhao, Y. Y. (2023). Deciphering the role of lipoproteins and lipid metabolic alterations in ageing and ageing-associated renal fibrosis. Ageing Research Reviews, 85, 101861. https://doi.org/10.1016/j.arr.2023.101861
Vancouver
Liu HJ, Miao H, Yang JZ, Liu F, Cao G, Zhao YY. Deciphering the role of lipoproteins and lipid metabolic alterations in ageing and ageing-associated renal fibrosis. Ageing Research Reviews. 2023;85:101861. doi:10.1016/j.arr.2023.101861
BibTeX
@article{Liu2023,
author = {Liu, Hong-Jiao and Miao, Hua and Yang, Jun-Zheng and Liu, Fei and Cao, Gang and Zhao, Ying-Yong},
title = {Deciphering the role of lipoproteins and lipid metabolic alterations in ageing and ageing-associated renal fibrosis},
journal = {Ageing Research Reviews},
year = {2023},
volume = {85},
pages = {101861},
doi = {10.1016/j.arr.2023.101861}
}
EUVIMED